Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe

Figure 1

Annual number HPV 16/18 related carcinoma cases among males and females when considering a vaccination strategy of boys and girls aged 12 versus girls only vaccination aged 12 (70% vaccine coverage rates assumed for all cohorts) - base case analysis presented at steady-state, 100 years. The remaining annual burden of male HPV-related carcinomas is shown in the chart on the left side; remaining burden of female HPV-related carcinomas is shown in the chart on the right hand side.

Back to article page